Cargando…
CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
BACKGROUND: Cervical cancer has ranked the top one in gynecological malignancies for incidence. Radioresistance is now becoming a leading reason of recurrence. METHODS: Our microRNA array data indicated that the miRNA-100 level decreased significantly during radioresistance. In this study, we up-reg...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044740/ https://www.ncbi.nlm.nih.gov/pubmed/35477450 http://dx.doi.org/10.1186/s12935-022-02573-3 |
_version_ | 1784695169205927936 |
---|---|
author | Yao, Tingting Yao, Yao Chen, Zhiliao Peng, Yongpai Zhong, Guanglei Huang, Chunxian Li, Jing Li, Ruixin |
author_facet | Yao, Tingting Yao, Yao Chen, Zhiliao Peng, Yongpai Zhong, Guanglei Huang, Chunxian Li, Jing Li, Ruixin |
author_sort | Yao, Tingting |
collection | PubMed |
description | BACKGROUND: Cervical cancer has ranked the top one in gynecological malignancies for incidence. Radioresistance is now becoming a leading reason of recurrence. METHODS: Our microRNA array data indicated that the miRNA-100 level decreased significantly during radioresistance. In this study, we up-regulated miR-100 in Hela and Siha cells by using miR-100 mimics and observed proliferation and invasion. RESULTS: It turned out that with overexpression of miR-100, the cells had less invasiveness as well as proliferation. It may target gene mTOR, and it deed reduced EMT. To examine the role of miR-100 in radioresistance, there was no significant result showed by BSP. While the circCASC15 has been identified with sponge function according to RNA pull down and ISH. CONCLUSION: The conclusions indicate miR-100 is a tumor suppressor gene and could be a therapeutic target in radio-resistant cervical cancers. |
format | Online Article Text |
id | pubmed-9044740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90447402022-04-28 CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance Yao, Tingting Yao, Yao Chen, Zhiliao Peng, Yongpai Zhong, Guanglei Huang, Chunxian Li, Jing Li, Ruixin Cancer Cell Int Primary Research BACKGROUND: Cervical cancer has ranked the top one in gynecological malignancies for incidence. Radioresistance is now becoming a leading reason of recurrence. METHODS: Our microRNA array data indicated that the miRNA-100 level decreased significantly during radioresistance. In this study, we up-regulated miR-100 in Hela and Siha cells by using miR-100 mimics and observed proliferation and invasion. RESULTS: It turned out that with overexpression of miR-100, the cells had less invasiveness as well as proliferation. It may target gene mTOR, and it deed reduced EMT. To examine the role of miR-100 in radioresistance, there was no significant result showed by BSP. While the circCASC15 has been identified with sponge function according to RNA pull down and ISH. CONCLUSION: The conclusions indicate miR-100 is a tumor suppressor gene and could be a therapeutic target in radio-resistant cervical cancers. BioMed Central 2022-04-27 /pmc/articles/PMC9044740/ /pubmed/35477450 http://dx.doi.org/10.1186/s12935-022-02573-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Yao, Tingting Yao, Yao Chen, Zhiliao Peng, Yongpai Zhong, Guanglei Huang, Chunxian Li, Jing Li, Ruixin CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance |
title | CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance |
title_full | CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance |
title_fullStr | CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance |
title_full_unstemmed | CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance |
title_short | CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance |
title_sort | circcasc15-mir-100-mtor may influence the cervical cancer radioresistance |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044740/ https://www.ncbi.nlm.nih.gov/pubmed/35477450 http://dx.doi.org/10.1186/s12935-022-02573-3 |
work_keys_str_mv | AT yaotingting circcasc15mir100mtormayinfluencethecervicalcancerradioresistance AT yaoyao circcasc15mir100mtormayinfluencethecervicalcancerradioresistance AT chenzhiliao circcasc15mir100mtormayinfluencethecervicalcancerradioresistance AT pengyongpai circcasc15mir100mtormayinfluencethecervicalcancerradioresistance AT zhongguanglei circcasc15mir100mtormayinfluencethecervicalcancerradioresistance AT huangchunxian circcasc15mir100mtormayinfluencethecervicalcancerradioresistance AT lijing circcasc15mir100mtormayinfluencethecervicalcancerradioresistance AT liruixin circcasc15mir100mtormayinfluencethecervicalcancerradioresistance |